Biomimix, Inc.
BMMX
Other OTC0.00
USD
- -
- -
ISIN
US09071A1025
Return %
Stock
S&P500
1Y
-93.33
26.84
3Y
-93.33
77.03
5Y
-93.33
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jeff Conroy
- Full Time Employees
- 1
- Sector
- Industrials
- Industry
- Conglomerates
- Address
- United States of America
- IPO Date
- Aug 23, 2000
- Similar Companies
- Business
- Biomimix, Inc. (BMMX) develops and commercializes biomimicry-based products and technologies that model nature's processes, systems, and elements to address medical needs, operating in the life science tools and services market spanning genomics, proteomics, cell biology, and analytical chemistry; through its subsidiary C'watre LLC, the company provides a skincare line formulated with molecularly stimulated ocean water containing 78 nanonutrients, including kanreki wash, kanreki tonic, kanreki cream, kanreki serum, haeru activating ageless serum, and c’tea Skincare From Within for professional spas, resorts, medical centers, and retail beauty outlets. Note that BiomimX Srl, an unrelated Italian entity and spin-off of Politecnico di Milano founded in recent years with headquarters in Milano, pioneers beating organs-on-chip platforms like the proprietary uBeat technology for dynamic 3D cell culture models including uHeart (beating human heart-on-chip), uKnee (healthy and osteoarthritic cartilage), uGut (gastrointestinal tract with epithelium and endothelium), and uScar (cardiac fibrosis), alongside services for drug discovery, safety-toxicology testing, efficacy prediction in disease models, advanced therapies, and microbiome interactions, but lacks direct affiliation with BMMX. The company maintains a public listing on OTC Markets with limited recent operational disclosures; no major funding rounds, acquisitions, partnerships, or strategic shifts within the last 1-2 years are publicly reported as of December 2025, though historical activities include skincare product commercialization via C'watre.